A clinical trial for two potential Ebola treatments, MBP134 and remdesivir, has commenced in DR Congo to combat the deadly Bundibugyo strain. Learn more ab

The Bundibugyo strain has no approved vaccine or targeted treatment, leaving supportive care as the primary option.

More than 1,400 people have been diagnosed and 438 have died